595 related articles for article (PubMed ID: 19655105)
1. Migraine.
Benemei S; Nicoletti P; Capone JG; De Cesaris F; Geppetti P
Handb Exp Pharmacol; 2009; (194):75-89. PubMed ID: 19655105
[TBL] [Abstract][Full Text] [Related]
2. Blockade of calcitonin gene-related peptide release after superior sagittal sinus stimulation in cat: a comparison of avitriptan and CP122,288.
Knight YE; Edvinsson L; Goadsby PJ
Neuropeptides; 1999 Feb; 33(1):41-6. PubMed ID: 10657470
[TBL] [Abstract][Full Text] [Related]
3. Calcitonin receptor-like receptor (CLR), receptor activity-modifying protein 1 (RAMP1), and calcitonin gene-related peptide (CGRP) immunoreactivity in the rat trigeminovascular system: differences between peripheral and central CGRP receptor distribution.
Lennerz JK; Rühle V; Ceppa EP; Neuhuber WL; Bunnett NW; Grady EF; Messlinger K
J Comp Neurol; 2008 Mar; 507(3):1277-99. PubMed ID: 18186028
[TBL] [Abstract][Full Text] [Related]
4. Selective inhibition of 5-HT7 receptor reduces CGRP release in an experimental model for migraine.
Wang X; Fang Y; Liang J; Yin Z; Miao J; Luo N
Headache; 2010 Apr; 50(4):579-87. PubMed ID: 20236348
[TBL] [Abstract][Full Text] [Related]
5. New migraine and pain research.
Hargreaves R
Headache; 2007 Apr; 47 Suppl 1():S26-43. PubMed ID: 17425708
[TBL] [Abstract][Full Text] [Related]
6. Neurogenic inflammation in the context of migraine.
Williamson DJ; Hargreaves RJ
Microsc Res Tech; 2001 May; 53(3):167-78. PubMed ID: 11301492
[TBL] [Abstract][Full Text] [Related]
7. Calcitonin gene-related peptide antagonists as treatments of migraine and other primary headaches.
Goadsby PJ
Drugs; 2005; 65(18):2557-67. PubMed ID: 16392873
[TBL] [Abstract][Full Text] [Related]
8. Migraine models.
Benemei S; De Cesaris F; Nicoletti P; Materazzi S; Nassini R; Geppetti P
Methods Mol Biol; 2010; 617():105-14. PubMed ID: 20336417
[TBL] [Abstract][Full Text] [Related]
9. CGRP receptors in the control of pain and inflammation.
Benemei S; Nicoletti P; Capone JG; Geppetti P
Curr Opin Pharmacol; 2009 Feb; 9(1):9-14. PubMed ID: 19157980
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological characterization of MK-0974 [N-[(3R,6S)-6-(2,3-difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide], a potent and orally active calcitonin gene-related peptide receptor antagonist for the treatment of migraine.
Salvatore CA; Hershey JC; Corcoran HA; Fay JF; Johnston VK; Moore EL; Mosser SD; Burgey CS; Paone DV; Shaw AW; Graham SL; Vacca JP; Williams TM; Koblan KS; Kane SA
J Pharmacol Exp Ther; 2008 Feb; 324(2):416-21. PubMed ID: 18039958
[TBL] [Abstract][Full Text] [Related]
11. CGRP and migraine: neurogenic inflammation revisited.
Geppetti P; Capone JG; Trevisani M; Nicoletti P; Zagli G; Tola MR
J Headache Pain; 2005 Apr; 6(2):61-70. PubMed ID: 16362644
[TBL] [Abstract][Full Text] [Related]
12. The trigemino-vascular system and migraine.
Buzzi MG; Moskowitz MA
Pathol Biol (Paris); 1992 Apr; 40(4):313-7. PubMed ID: 1379707
[TBL] [Abstract][Full Text] [Related]
13. Neurogenic inflammation and migraine: implications for the therapeutics.
Peroutka SJ
Mol Interv; 2005 Oct; 5(5):304-11. PubMed ID: 16249526
[TBL] [Abstract][Full Text] [Related]
14. Treatment of migraine attacks based on the interaction with the trigemino-cerebrovascular system.
Link AS; Kuris A; Edvinsson L
J Headache Pain; 2008 Feb; 9(1):5-12. PubMed ID: 18217201
[TBL] [Abstract][Full Text] [Related]
15. Orexin 1 receptor activation attenuates neurogenic dural vasodilation in an animal model of trigeminovascular nociception.
Holland PR; Akerman S; Goadsby PJ
J Pharmacol Exp Ther; 2005 Dec; 315(3):1380-5. PubMed ID: 16160082
[TBL] [Abstract][Full Text] [Related]
16. Salivary levels of CGRP and VIP in rhinosinusitis and migraine patients.
Bellamy JL; Cady RK; Durham PL
Headache; 2006 Jan; 46(1):24-33. PubMed ID: 16412148
[TBL] [Abstract][Full Text] [Related]
17. CGRP and the Trigeminal System in Migraine.
Iyengar S; Johnson KW; Ossipov MH; Aurora SK
Headache; 2019 May; 59(5):659-681. PubMed ID: 30982963
[TBL] [Abstract][Full Text] [Related]
18. Targeting CGRP: A New Era for Migraine Treatment.
Wrobel Goldberg S; Silberstein SD
CNS Drugs; 2015 Jun; 29(6):443-52. PubMed ID: 26138383
[TBL] [Abstract][Full Text] [Related]
19. CGRP in the trigeminovascular system: a role for CGRP, adrenomedullin and amylin receptors?
Walker CS; Hay DL
Br J Pharmacol; 2013 Dec; 170(7):1293-307. PubMed ID: 23425327
[TBL] [Abstract][Full Text] [Related]
20. Cortical spreading depression as a site of origin for migraine: Role of CGRP.
Close LN; Eftekhari S; Wang M; Charles AC; Russo AF
Cephalalgia; 2019 Mar; 39(3):428-434. PubMed ID: 29695168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
